Royalty Pharma plc
RPRX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $929 | $477 | $1,711 | $1,541 |
| Short-Term Investments | $842 | $757 | $717 | $1,262 |
| Receivables | $27 | $22 | $37 | $68 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $4 | $18 | $91 | $7 |
| Total Curr. Assets | $1,802 | $1,274 | $2,555 | $2,878 |
| Property Plant & Equip (Net) | $0 | $0 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $15,127 | $0 | $0 | $6 |
| Long-Term Investments | $16,387 | $15,101 | $14,229 | $14,628 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | -$15,094 | $7 | $30 | $4 |
| Total NC Assets | $16,421 | $15,108 | $14,259 | $14,638 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $18,223 | $16,382 | $16,813 | $17,516 |
| Liabilities | – | – | – | – |
| Payables | $13 | $15 | $8 | $6 |
| Short-Term Debt | $998 | $0 | $998 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $242 | $146 | $161 | $166 |
| Total Curr. Liab. | $1,254 | $161 | $1,167 | $171 |
| LT Debt | $6,615 | $6,135 | $6,119 | $7,096 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $12 | $1 | $3 | $0 |
| Total NC Liab. | $6,627 | $6,136 | $6,121 | $7,096 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $7,880 | $6,298 | $7,288 | $7,267 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | $2,846 | $2,518 | $1,965 | $2,255 |
| AOCI | $0 | $0 | $0 | $16 |
| Other Equity | $4,101 | $4,009 | $3,663 | $3,505 |
| Total Equity | $6,947 | $6,526 | $5,628 | $5,777 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $3,396 | $3,558 | $3,897 | $4,472 |
| Total Liab. & Tot. Equity | $18,223 | $16,382 | $16,813 | $17,516 |
| Net Debt | $6,683 | $5,658 | $5,406 | $5,555 |